Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R John Simes

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Statistics in Medicine|December 17, 2013
Semiparametric methods for multistate survival models in randomised trialsHarold M Hudson, Serigne N Lô, R John Simes, et al.
BMJ Open|February 25, 2014
Which lipid measurement should we monitor? An analysis of the LIPID studyPaul P Glasziou, Les Irwig, Adrienne C Kirby, et al.
The Medical Journal of Australia|July 16, 2015
Australian clinical trial activity and burden of disease: an analysis of registered trials in National Health Priority AreasJacquelyne Lam, Sarah J Lord, Kylie E Hunter, et al.
Diabetes Care|January 11, 2008
Can self-rated health scores be used for risk prediction in patients with type 2 diabetes?Alison J Hayes, Philip M Clarke, Paul G Glasziou, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's ageSanneke P M de Boer, Cynthia M Westerhout, R John Simes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2012
Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with temsirolimusChee Khoon Lee, Ian C Marschner, R John Simes, et al.
The New Zealand Medical Journal|February 19, 2008
Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) StudyRalph A Stewart, Fiona M North, Katrina J Sharples, et al.
Annals of Surgical Oncology|October 16, 2014
Sentinel lymph node based management or routine axillary clearance? Three-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trialNeil Wetzig, Peter Grantley Gill, Diana Zannino, et al.
BMC Medical Research Methodology|February 16, 2012
Using patient management as a surrogate for patient health outcomes in diagnostic test evaluationLukas P Staub, Sarah J Lord, R John Simes, et al.
The Lancet. Oncology|June 21, 2011
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisKatrin M Sjoquist, Bryan H Burmeister, B Mark Smithers, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Statistics in Medicine|December 17, 2013
Semiparametric methods for multistate survival models in randomised trialsHarold M Hudson, Serigne N Lô, R John Simes, et al.
BMJ Open|February 25, 2014
Which lipid measurement should we monitor? An analysis of the LIPID studyPaul P Glasziou, Les Irwig, Adrienne C Kirby, et al.
The Medical Journal of Australia|July 16, 2015
Australian clinical trial activity and burden of disease: an analysis of registered trials in National Health Priority AreasJacquelyne Lam, Sarah J Lord, Kylie E Hunter, et al.
Diabetes Care|January 11, 2008
Can self-rated health scores be used for risk prediction in patients with type 2 diabetes?Alison J Hayes, Philip M Clarke, Paul G Glasziou, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's ageSanneke P M de Boer, Cynthia M Westerhout, R John Simes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2012
Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with temsirolimusChee Khoon Lee, Ian C Marschner, R John Simes, et al.
The New Zealand Medical Journal|February 19, 2008
Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) StudyRalph A Stewart, Fiona M North, Katrina J Sharples, et al.
Annals of Surgical Oncology|October 16, 2014
Sentinel lymph node based management or routine axillary clearance? Three-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trialNeil Wetzig, Peter Grantley Gill, Diana Zannino, et al.
BMC Medical Research Methodology|February 16, 2012
Using patient management as a surrogate for patient health outcomes in diagnostic test evaluationLukas P Staub, Sarah J Lord, R John Simes, et al.
The Lancet. Oncology|June 21, 2011
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisKatrin M Sjoquist, Bryan H Burmeister, B Mark Smithers, et al.
Pageof 8